Caitong International Asset Management’s Decoy Therapeutics DCOY Stock Holding History

Caitong International Asset Management’s Portfolio DCOY Stock Details DCOY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14	Buy	+2	New	+$12	﹤0.01%	2587

Other funds holding DCOY

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Caitong International Asset Management's DCOY Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Decoy Therapeutics (DCOY) in Q2 2026: 2 shares worth $14. The stake represents ﹤0.01% of the portfolio and ranks #2587 among its holdings.

4 funds tracked by Wall St. Rank hold DCOY as of Q2 2026.

Caitong International Asset Management held 2 shares of Decoy Therapeutics worth $14 as of Q2 2026.
Decoy Therapeutics was a new Caitong International Asset Management position in Q2 2026.
Decoy Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2587 holding.
4 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.